title: Telomerase as a useful target in cancer fighting-the breast cancer case.
abstract: Telomerase was initially considered as a relevant factor distinguishing cancer from normal cells. During detailed studies, it appeared that its expression and activity is not only limited to cancer cells however, but in this particular cells, the telomerase is much more abundant. Thus, it has become a very promising target for an anticancer therapy. It was revealed in many studies that regulation of telomerase is a multifactorial process in mammalian cells, involving regulation of expression of telomerase subunits coding genes, post-translational protein-protein interactions, and protein phosphorylation. Numerous proto-oncogenes and tumor suppressor genes are engaged in this mechanism, and the complexity of telomerase control is studied in the context of tumor development as well as aging. Additionally, since numerous studies reveal a correlation between short telomeres and increased genome instability or cell mortality, the telomerase control appears to be one of the crucial factors to study in order to improve the cancer diagnostics and therapy or prevention. Interestingly, almost 100 % of adenocarcinoma, including breast cancer cells, expresses telomerase which makes it a good target for telomerase-related therapy. Additionally, telomerase is also supposed to be associated with drug resistance. Thus, targeting the enzyme might result in attenuation of this phenomenon. Moreover, since stem cells existence was reported, it must be considered whether targeting telomerase can bring some serious side effects and result in stem cells viability or their regenerative potential decrease. Thus, we review some molecular mechanisms engaged in therapy based on targeting telomerase in breast cancer cells.
authors.affiliation: Department of Clinical Chemistry and Molecular Diagnostics, Poznan University of Medical Sciences, ul. Przybyszewskiego 49, 60-355, Poznan, Poland.
authors.forename: Hanna
authors.initials: H
authors.lastname: Holysz
authors.forename: Natalia
authors.initials: N
authors.lastname: Lipinska
authors.forename: Anna
authors.initials: A
authors.lastname: Paszel-Jaworska
authors.forename: Blazej
authors.initials: B
authors.lastname: Rubis
mesh_terms: D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000201:enzymology / Q000235:genetics; D005260:Female; D006801:Humans; D019098:Telomerase / Q000037:antagonists & inhibitors* / Q000235:genetics
chemical_list: D000970:Antineoplastic Agents; D019098:Telomerase
references.citation: Mol Cancer. 2005 Jul 15;4:24
references.pmid: 16022731
references.citation: J Natl Cancer Inst. 2009 Apr 1;101(7):488-97
references.pmid: 19318640
references.citation: Science. 1994 Dec 23;266(5193):2011-5
references.pmid: 7605428
references.citation: J Biol Chem. 2005 Dec 9;280(49):40402-5
references.pmid: 16234237
references.citation: Genes Dev. 2004 Sep 15;18(18):2269-82
references.pmid: 15371341
references.citation: BMC Cancer. 2009 May 05;9:133
references.pmid: 19416503
references.citation: Int J Oncol. 2009 Nov;35(5):1141-9
references.pmid: 19787269
references.citation: Oncol Res. 2009;17(9):413-23
references.pmid: 19718948
references.citation: Circ Res. 2006 Apr 14;98(7):e50-9
references.pmid: 16556873
references.citation: J Exp Clin Cancer Res. 2004 Jun;23(2):309-16
references.pmid: 15354417
references.citation: Invest New Drugs. 2009 Aug;27(4):289-96
references.pmid: 18773143
references.citation: Anticancer Res. 2009 Jul;29(7):2845-9
references.pmid: 19596972
references.citation: Nature. 2010 Mar 25;464(7288):520-8
references.pmid: 20336134
references.citation: Gynecol Oncol. 2006 May;101(2):305-10
references.pmid: 16380156
references.citation: J Biol Chem. 2003 Oct 31;278(44):43363-72
references.pmid: 12917431
references.citation: Nucleic Acids Res. 2005 Dec 02;33(21):6850-60
references.pmid: 16326864
references.citation: Acta Pharmacol Sin. 2006 Sep;27(9):1185-91
references.pmid: 16923339
references.citation: Cancer Res. 2005 Aug 1;65(15):6516-20
references.pmid: 16061629
references.citation: J Exp Clin Cancer Res. 2011 Jan 06;30:1
references.pmid: 21208462
references.citation: Nucleic Acids Res. 2007;35(4):1245-56
references.pmid: 17267411
references.citation: J Biol Chem. 2012 Nov 30;287(49):41297-309
references.pmid: 23055531
references.citation: Eur J Cancer. 1997 Apr;33(5):787-91
references.pmid: 9282118
references.citation: Nucleic Acids Res. 2000 Jul 1;28(13):2557-62
references.pmid: 10871406
references.citation: Cancer Res. 1999 Dec 1;59(23):5917-21
references.pmid: 10606235
references.citation: Oncogene. 2006 Nov 30;25(56):7411-20
references.pmid: 16767163
references.citation: Oncogene. 2002 Jan 21;21(4):643-9
references.pmid: 11850791
references.citation: Anticancer Res. 2009 Dec;29(12):4959-64
references.pmid: 20044602
references.citation: Arch Pharm Res. 2009 Oct;32(10):1351-60
references.pmid: 19898796
references.citation: Biochem Biophys Res Commun. 2006 Nov 3;349(4):1361-7
references.pmid: 16979586
references.citation: Nature. 2007 Feb 1;445(7127):506-10
references.pmid: 17237768
references.citation: Science. 2006 Oct 13;314(5797):268-74
references.pmid: 16959974
references.citation: EMBO J. 1995 Sep 1;14(17):4240-8
references.pmid: 7556065
references.citation: Nat Med. 2005 Sep;11(9):920-2
references.pmid: 16145569
references.citation: Mol Cell Biol. 2004 Jan;24(1):25-35
references.pmid: 14673140
references.citation: Cancer Res. 2003 Sep 15;63(18):5917-25
references.pmid: 14522918
references.citation: Zhonghua Zhong Liu Za Zhi. 1999 Sep;21(5):350-3
references.pmid: 11776572
references.citation: FEBS Lett. 2008 Oct 15;582(23-24):3263-9
references.pmid: 18775701
references.citation: Genes Dev. 2005 Sep 15;19(18):2100-10
references.pmid: 16166375
references.citation: Ann N Y Acad Sci. 2007 Oct;1114:36-47
references.pmid: 17986575
references.citation: Int J Cancer. 2001 Apr 15;92(2):195-202
references.pmid: 11291045
references.citation: J Biol Chem. 2005 Apr 29;280(17):17329-38
references.pmid: 15734740
references.citation: J Biol Chem. 2004 Nov 5;279(45):47264-71
references.pmid: 15316005
references.citation: Int J Cancer. 2011 Dec 15;129(12):2765-74
references.pmid: 21671468
references.citation: Arch Pharm Res. 2009 Sep;32(9):1263-9
references.pmid: 19784583
references.citation: Nature. 1997 Sep 11;389(6647):191-4
references.pmid: 9296498
references.citation: Mol Cancer Ther. 2009 May;8(5):1319-27
references.pmid: 19417141
references.citation: Nat Genet. 1999 Feb;21(2):220-4
references.pmid: 9988278
references.citation: J Biol Chem. 1999 Dec 24;274(52):37473-8
references.pmid: 10601322
references.citation: Stem Cells Dev. 2011 Jan;20(1):149-57
references.pmid: 20486780
references.citation: Mol Cell Biol. 2000 Jun;20(11):3764-71
references.pmid: 10805720
references.citation: Cancer Sci. 2008 Jul;99(7):1401-6
references.pmid: 18460021
references.citation: Cancer Res. 2007 Feb 1;67(3):1130-7
references.pmid: 17283147
references.citation: J Cell Biochem. 2002;86(1):174-83
references.pmid: 12112028
references.citation: Cytotechnology. 2010 Aug;62(4):333-9
references.pmid: 20454928
references.citation: J Biol Chem. 2009 Dec 25;284(52):36083-36098
references.pmid: 19797051
references.citation: FEBS Lett. 2005 Feb 14;579(5):1027-33
references.pmid: 15710386
references.citation: Mol Biol Rep. 2011 Jun;38(5):3339-49
references.pmid: 21086176
references.citation: Int J Cancer. 2009 Jul 15;125(2):286-96
references.pmid: 19358274
references.citation: Mol Cell Biol. 2011 Jul;31(13):2605-17
references.pmid: 21536653
references.citation: Annu Rev Genet. 2008;42:301-34
references.pmid: 18680434
references.citation: Proc Natl Acad Sci U S A. 2002 Jul 9;99(14):9316-21
references.pmid: 12084816
references.citation: J Virol. 2002 Dec;76(24):12813-22
references.pmid: 12438606
references.citation: Cancer Res. 2002 Jul 1;62(13):3876-82
references.pmid: 12097303
references.citation: Oncogene. 1998 Jul 16;17(2):187-97
references.pmid: 9674703
references.citation: Science. 1995 Dec 8;270(5242):1663-7
references.pmid: 7502076
references.citation: Cancer Res. 2010 Nov 1;70(21):8684-94
references.pmid: 20837664
references.citation: Carcinogenesis. 2003 Jul;24(7):1167-76
references.pmid: 12807729
references.citation: Cell. 1997 Aug 22;90(4):809-19
references.pmid: 9288759
references.citation: Mol Cancer Ther. 2009 Jul;8(7):2027-35
references.pmid: 19509275
references.citation: Cell. 1997 Aug 22;90(4):785-95
references.pmid: 9288757
references.citation: BMC Cancer. 2001;1:10
references.pmid: 11518543
references.citation: Cancer Res. 2010 Nov 15;70(22):9494-504
references.pmid: 21062983
references.citation: Leuk Res. 2011 Mar;35(3):416-8
references.pmid: 21163530
references.citation: Mol Cancer. 2010 Jan 20;9:10
references.pmid: 20085660
references.citation: PLoS One. 2010 Aug 25;5(8):e12407
references.pmid: 20811636
references.citation: Cancer Lett. 2008 Sep 18;268(2):272-7
references.pmid: 18479810
references.citation: J Biol Chem. 2002 Jun 7;277(23):20965-73
references.pmid: 11916966
references.citation: Oncogene. 2006 Aug 3;25(33):4505-14
references.pmid: 16619047
references.citation: Cancer Cell. 2005 Jun;7(6):505-12
references.pmid: 15950900
references.citation: Int J Oncol. 2009 Apr;34(4):1061-8
references.pmid: 19287963
references.citation: Biochem Biophys Res Commun. 2010 Mar 26;394(1):59-63
references.pmid: 20171193
references.citation: J Virol. 2003 Sep;77(18):9852-61
references.pmid: 12941894
references.citation: Hum Mol Genet. 1999 Jan;8(1):137-42
references.pmid: 9887342
references.citation: Oncogene. 2003 Aug 11;22(33):5093-107
references.pmid: 12910247
references.citation: J Clin Invest. 2002 Jul;110(2):219-27
references.pmid: 12122114
references.citation: Biochem Biophys Res Commun. 2003 Mar 28;303(1):130-6
references.pmid: 12646176
references.citation: Br J Cancer. 2005 May 23;92(10):1881-91
references.pmid: 15870711
references.citation: Mutat Res. 2012 Feb 1;730(1-2):90-7
references.pmid: 21802433
references.citation: Oncogene. 2003 Sep 11;22(39):8042-7
references.pmid: 12970752
references.citation: J Natl Cancer Inst. 2008 Jan 16;100(2):98-108
references.pmid: 18182620
references.citation: Breast. 2009 Oct;18 Suppl 3:S51-4
references.pmid: 19914543
references.citation: Biochem Cell Biol. 2011 Aug;89(4):359-76
references.pmid: 21790308
references.citation: Cancer Res. 2000 Oct 1;60(19):5376-81
references.pmid: 11034074
references.citation: Cell Res. 2008 Jul;18(7):725-32
references.pmid: 18574498
references.citation: Eur J Cancer. 1997 Apr;33(5):781-6
references.pmid: 9282117
references.citation: Clin Cancer Res. 2000 Apr;6(4):1239-47
references.pmid: 10778946
references.citation: Oncogene. 2006 Feb 9;25(6):813-26
references.pmid: 16205639
references.citation: Cell. 2003 Jun 27;113(7):881-9
references.pmid: 12837246
references.citation: J Virol. 2001 Jun;75(12):5559-66
references.pmid: 11356963
references.citation: J Biol Chem. 2002 Sep 20;277(38):35509-15
references.pmid: 12101184
references.citation: Oncol Rep. 2010 Jul;24(1):271-6
references.pmid: 20514472
references.citation: Mod Pathol. 2011 Feb;24(2):194-200
references.pmid: 21057458
references.citation: Mol Cell Biol. 2003 Dec;23(23):8668-90
references.pmid: 14612409
references.citation: Oncogene. 2000 Oct 26;19(45):5123-33
references.pmid: 11064449
references.citation: Exp Mol Pathol. 2005 Oct;79(2):108-17
references.pmid: 16054129
references.citation: Endocr Rev. 1996 Dec;17(6):587-609
references.pmid: 8969970
references.citation: Exp Cell Res. 2010 Dec 10;316(20):3329-41
references.pmid: 20184882
references.citation: Curr Mol Med. 2005 Mar;5(2):233-41
references.pmid: 15974878
references.citation: Philos Trans R Soc Lond B Biol Sci. 2011 Jan 12;366(1561):76-84
references.pmid: 21115533
references.citation: Science. 1997 Aug 15;277(5328):955-9
references.pmid: 9252327
references.citation: Exp Cell Res. 1961 Dec;25:585-621
references.pmid: 13905658
references.citation: J Biol Chem. 2001 Jun 22;276(25):22971-8
references.pmid: 11313352
references.citation: Carcinogenesis. 2011 Sep;32(9):1315-23
references.pmid: 21693539
references.citation: Breast Cancer Res Treat. 2006 Mar;96(1):73-81
references.pmid: 16319992
references.citation: Mol Pharmacol. 2005 Sep;68(3):779-86
references.pmid: 15939802
references.citation: Int J Radiat Biol. 2011 Jun;87(6):609-21
references.pmid: 21627565
references.citation: PLoS One. 2010 Feb 09;5(2):e9132
references.pmid: 20161752
references.citation: Genes Dev. 1998 Jun 15;12(12):1769-74
references.pmid: 9637678
references.citation: PLoS One. 2010 Jul 06;5(7):e11457
references.pmid: 20625516